Avenue Therapeutics Valuation
| ATXI Stock | USD 0.38 0.02 5.56% |
Avenue Therapeutics seems to be fairly valued based on Macroaxis valuation methodology. Our model approximates the value of Avenue Therapeutics from analyzing the firm fundamentals such as return on equity of -5.35, and Current Valuation of (1.73 M) as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Avenue Therapeutics' price fluctuation is out of control at this time. Calculation of the real value of Avenue Therapeutics is based on 3 months time horizon. Increasing Avenue Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Avenue Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Avenue Pink Sheet. However, Avenue Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.38 | Real 0.36 | Hype 0.38 | Naive 0.18 |
The intrinsic value of Avenue Therapeutics' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Avenue Therapeutics' stock price.
Estimating the potential upside or downside of Avenue Therapeutics helps investors to forecast how Avenue pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Avenue Therapeutics more accurately as focusing exclusively on Avenue Therapeutics' fundamentals will not take into account other important factors: Avenue Therapeutics Total Value Analysis
Avenue Therapeutics is presently anticipated to have valuation of (1.73 M) with market capitalization of 862.65 K, debt of 1.2 M, and cash on hands of 890 K. The negative valuation of Avenue Therapeutics may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Avenue Therapeutics fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(1.73 M) | 862.65 K | 1.2 M | 890 K |
Avenue Therapeutics Asset Utilization
One of the ways to look at asset utilization of Avenue is to check how much profit was generated for every dollar of assets it reports. Avenue Therapeutics shows a negative utilization of assets of -4.72 percent, losing $0.0472 for each dollar of assets held by the firm. Unsuccessful asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Avenue Therapeutics shows how unproductive it operates for each dollar spent on its assets.Avenue Therapeutics Ownership Allocation
Avenue Therapeutics retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.Avenue Therapeutics Profitability Analysis
Net Loss for the year was (10.38 M) with profit before overhead, payroll, taxes, and interest of 0.About Avenue Therapeutics Valuation
An absolute valuation paradigm, as applied to Avenue Pink Sheet, attempts to find the value of Avenue Therapeutics based on its fundamental and basic technical indicators. By analyzing Avenue Therapeutics's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Avenue Therapeutics's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Avenue Therapeutics. We calculate exposure to Avenue Therapeutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Avenue Therapeutics's related companies.Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acuteintensive care hospital setting. The company was incorporated in 2015 and is based in New York, New York. Avenue Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people.
8 Steps to conduct Avenue Therapeutics' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Avenue Therapeutics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Avenue Therapeutics' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Avenue Therapeutics' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Avenue Therapeutics' revenue streams: Identify Avenue Therapeutics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Avenue Therapeutics' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Avenue Therapeutics' growth potential: Evaluate Avenue Therapeutics' management, business model, and growth potential.
- Determine Avenue Therapeutics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Avenue Therapeutics' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Avenue Therapeutics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 141.2 K | |
| Quarterly Earnings Growth Y O Y | -0.763 | |
| Forward Price Earnings | 17.9856 | |
| Shares Float | 1.4 M |
Complementary Tools for Avenue Pink Sheet analysis
When running Avenue Therapeutics' price analysis, check to measure Avenue Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avenue Therapeutics is operating at the current time. Most of Avenue Therapeutics' value examination focuses on studying past and present price action to predict the probability of Avenue Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avenue Therapeutics' price. Additionally, you may evaluate how the addition of Avenue Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |